,substring,calibr_id,smiles_x,inchi_key_x,rfm_id,calibr_id2,smiles_y,hvac_id,_merge,inchi_key_x_LDH,inchi_key_y_LDH,init_inchi_match,new_inchi_match
479,CBR-HVAC-05330,CBR-001-587-193-9,N#Cc1ccc2c(c1)CN([C@@H](CN2Cc1[nH]cnc1)Cc1ccccc1)S(=O)(=O)c1cccs1,OLCWFLWEHWLBTO-HSZRJFAPSA-N,RFM-006-446-0,CBR-001-587-193-9,N#Cc1ccc2c(c1)CN([C@@H](CN2Cc1nc[nH]c1)Cc1ccccc1)S(=O)(=O)c1cccs1,CBR-HVAC-05330: Oncolytic Drugs;Solid Tumors Therapy; Apoptosis Inducers;Farnesyltransferase (geranylgeranyl pyrophosphate synthase) Inhibitors;Signal Transduction Modulators; Ras GTPase; Protein farnesyltransferase Inhibitor;,both,OLCWFLWEHWLBTO-HSZRJFAPSA-N,OLCWFLWEHWLBTO-HSZRJFAPSA-N,TRUE,TRUE
532,CBR-HVAC-11486,CBR-001-574-507-0,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)Cc1cn3c([nH]c1=C2)nc1c3cccc1,UDARCLYIAYOQQB-HZVAOYAWSA-N,RFM-003-303-4,CBR-001-574-507-0,C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC[C@@H]2[C@]1(C)Cc1cn3c(nc1C2)nc1c3cccc1,CBR-HVAC-11486 Pharmacological Tools; Signal Transduction Modulators;Tachykinin NK1 Antagonists; Neurokinin receptor 1 Antagonist;,both,UDARCLYIAYOQQB-HZVAOYAWSA-N,AIIXYCDTEGICEE-HZVAOYAWSA-N,TRUE,FALSE
618,CBR-HVAC-12652,CBR-001-634-198-3,COC(=O)CCc1c2/C=C/3\N=C(C(=C3CCC(=O)O)C)/C=C/3\N/C(=C\C4=N/C(=C\c(c1C)n2)/C(=C4C)C=C)/C1=CC=C([C@H](C31C)C(=O)OC)C(=O)OC,,RFM-010-275-0,CBR-001-634-198-3,COC(=O)CCc1c2/C=C/3\N=C(C(=C3CCC(=O)O)C)/C=C/3\N/C(=C\C4=N/C(=C\c(c1C)[nH]2)/C(=C4C)C=C)/C1=CC=C([C@H](C31C)C(=O)OC)C(=O)OC,"CBR-HVAC-04687: Age-Related Macular Degeneration, Treatment of; Antipsoriatics; Oncolytic Drugs; Ophthalmic Drugs",both,,MNCZEEFHIBYYSK-PFPOWYEKSA-N,TRUE,FALSE
734,CBR-HVAC-01337,CBR-001-625-284-9,CN([C@@H]1C(=C(C(=O)N)C(=O)[C@@]2([C@H]1C[C@H]1C(=C2O)C(=O)c2c([C@H]1O)c(Cl)ccc2O)O)O)C,FMTDIUIBLCQGJB-SEYHBJAFSA-N,RFM-009-254-6,CBR-001-625-284-9,CN([C@@H]1C(=O)C(=C(C2([C@H]1C[C@H]1C(=C(O)c3c([C@H]1O)c(Cl)ccc3O)C2=O)O)O)C(=O)N)C,CBR-HVAC-01337: 16S-rRNA of 30S ribosomal subunit Binder; Antibacterial; Diuretic,both,FMTDIUIBLCQGJB-SEYHBJAFSA-N,GUXHBMASAHGULD-SMNOWXJTSA-N,TRUE,FALSE